🚀 VC round data is live in beta, check it out!

Hektaş Valuation Multiples

Discover revenue and EBITDA valuation multiples for Hektaş and similar public comparables like AquaChile, Nufarm, Blumar, AACo and more.

Hektaş Overview

About Hektaş

Hektas Ticaret AS is a Turkey-based company involved in producing and marketing agricultural and veterinary medicines. Its offerings include agrochemicals, such as insecticides, herbicides, fungicides, leaf fertilizers, growth regulators, and fumigants; and veterinary pharmaceuticals. The majority of revenue is derived from domestic sales.


Founded

1956

HQ

Turkey

Employees

579

Financials (FY)

Revenue: $111M
EBITDA: $56M

EV

$806M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Hektaş Financials

Hektaş reported last fiscal year revenue of $111M and EBITDA of $56M.

In the same fiscal year, Hektaş generated ($23M) in gross profit, $56M in EBITDA, and had net loss of ($62M).


Hektaş P&L

In the most recent fiscal year, Hektaş reported revenue of $111M and EBITDA of $56M.

Hektaş expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Hektaş forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$111MXXXXXXXXX
Gross ProfitXXX($23M)XXXXXXXXX
Gross MarginXXX(21%)XXXXXXXXX
EBITDAXXX$56MXXXXXXXXX
EBITDA MarginXXX50%XXXXXXXXX
EBIT MarginXXX(59%)XXXXXXXXX
Net ProfitXXX($62M)XXXXXXXXX
Net MarginXXX(56%)XXXXXXXXX
Net Debt$109MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Hektaş Stock Performance

Hektaş has current market cap of $622M, and enterprise value of $806M.

Market Cap Evolution


Hektaş's stock price is $0.07.

See Hektaş trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$806M$622M(0.3%)XXXXXXXXX$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Hektaş Valuation Multiples

Hektaş trades at 7.3x EV/Revenue multiple, and 14.5x EV/EBITDA.

See valuation multiples for Hektaş and 15K+ public comps

Hektaş Financial Valuation Multiples

As of March 7, 2026, Hektaş has market cap of $622M and EV of $806M.

Equity research analysts estimate Hektaş's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Hektaş has a P/E ratio of (10.0x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$622MXXX$622MXXXXXXXXX
EV (current)$806MXXX$806MXXXXXXXXX
EV/RevenueXXX7.3xXXXXXXXXX
EV/EBITDAXXX14.5xXXXXXXXXX
EV/EBITXXX(12.4x)XXXXXXXXX
EV/Gross ProfitXXX(35.1x)XXXXXXXXX
P/EXXX(10.0x)XXXXXXXXX
EV/FCFXXX10.7xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Hektaş Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Hektaş Margins & Growth Rates

Hektaş's revenue in the last fiscal year declined by (19%).

See operational valuation multiples for Hektaş and other 15K+ public comps

Hektaş Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX(19%)XXXXXXXXX
EBITDA MarginXXX50%XXXXXXXXX
EBITDA GrowthXXX(16%)XXXXXXXXX
S&M Expenses to RevenueXXX2%XXXXXXXXX
G&A Expenses to RevenueXXX3%XXXXXXXXX
R&D Expenses to RevenueXXX8%XXXXXXXXX
Opex to RevenueXXX38%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Hektaş Public Comps

See public comps and valuation multiples for other Agriculture comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
AquaChileXXXXXXXXXXXXXXXXXX
NufarmXXXXXXXXXXXXXXXXXX
BlumarXXXXXXXXXXXXXXXXXX
AACoXXXXXXXXXXXXXXXXXX
EndurXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Hektaş M&A Activity

Hektaş acquired XXX companies to date.

Last acquisition by Hektaş was on XXXXXXXX, XXXXX. Hektaş acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Hektaş

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Hektaş Investment Activity

Hektaş invested in XXX companies to date.

Hektaş made its latest investment on XXXXXXXX, XXXXX. Hektaş invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Hektaş

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Hektaş

When was Hektaş founded?Hektaş was founded in 1956.
Where is Hektaş headquartered?Hektaş is headquartered in Turkey.
How many employees does Hektaş have?As of today, Hektaş has over 579 employees.
Is Hektaş publicly listed?Yes, Hektaş is a public company listed on Borsa Istanbul.
What is the stock symbol of Hektaş?Hektaş trades under HEKTS ticker.
When did Hektaş go public?Hektaş went public in 1986.
Who are competitors of Hektaş?Hektaş main competitors are AquaChile, Nufarm, Blumar, AACo.
What is the current market cap of Hektaş?Hektaş's current market cap is $622M.
What is the current revenue of Hektaş?Hektaş's last fiscal year revenue is $111M.
What is the current EV/Revenue multiple of Hektaş?Current revenue multiple of Hektaş is 7.3x.
Is Hektaş profitable?No, Hektaş is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial